27th – 28th February 2006, in Manchester, UK.

Oxford International are pleased to announce their inaugural Biomarkers Discovery and Development Congress, being held on 27th – 28th February 2006, in Manchester, UK. The 6th in our series of Drug Discovery events, the congress offers attendees an unprecedented opportunity to network with leading senior-level R&D executives. The program will address the key role of biomarkers within the future of drug discovery and development, and consider the challenges, costs and benefits involved in developing, discovering and integrating biomarker applications.

Frost & Sullivan takes pride in announcing the presence of Dr. Amarpreet Dhiman, Industry Analyst, Healthcare Practice, Frost & Sullivan (EMEA) at the conference. Dr. Dhiman will be making a presentation on ‘Biomarkers in Clinical Trials’ highlighting various applications and case-studies.

An exemplary panel of industry speakers will provide focused industry case study presentations and interactive panel discussions regarding:

• Strategy: Biomarkers as a means of empowering decision-making, reducing costs and increasing productivity
• Technologies: Imaging biomarkers and molecular biomarkers
• Biomarkers as markers of activity and surrogate endpoints
• Regulation: Constraints and challenges
• Biomarkers in the preclinical phase
• Efficacy models
• Metabolomic, genomic and proteomic applications
• Clinical validation of biomarkers
• Toxicity biomarkers: safety, validation and efficacy testing

Attendees will be from leading Pharmaceutical and Biotech companies, including Vice Presidents, Directors and Scientific Leaders of:

• Drug and Safety Assessment	• Early Clinical Development
• Biomarker Discovery/Validation	• Drug Metabolism/Pharmacokinetics
• Diagnostics	• Clinical Pathology
• Proteomics/Genomics/Metabolomics	• Molecular and Cell Biology
• Clinical Pharmacology	• Preclinical Development
• Toxicology/Toxicogenomics	• Pharmacokinetics/Pharmacodynamics   (PKPD)
• Experimental Medicine

Networking Opportunities

Delegates will have the chance to meet face-to-face with leading solution providers and senior-level industry peers to discuss technologies, services and solutions that address business concerns.

Categories of solution providers represented include:

• Biomarker Discovery
• Proteomics
• Diagnostics
• Platform Technologies
• Genomics
• Metabolomics
• Molecular Profiling
• Modelling and Simulation

For more information on the conference or to obtain a copy of our presentation document, kindly contact Srividhya Parthasarathy on +44 (0) 20 7343 8376 or email her at sparthasarathy@frost.com.